Andrew Preston joined de Poel healthcare in 2013 as managing director and was responsible for a period of significant growth, which led to his appointment in 2015 as group managing director. Following a September 2016 management buyout, which he led, Preston became CEO and is currently delivering record revenue and double-digit EBITDA growth for the UKbased firm. Preston has worked in healthcare and the wider public sector for almost 20 years after starting his career in the National Health Service. An experienced business leader with a global health background — including the sale of his own clinical service business to global service provider Serco Group plc — Preston has experience in growth and development of FTSE 100 companies, PLCs, private equity-backed and private organisations.
